药物对比
Canagliflozin vs Pramlintide
比较Canagliflozin（Invokana）与Pramlintide（Symlin）——口服SGLT2抑制剂与注射用胰淀素类似物，用于2型糖尿病的治疗管理与安全性。
此页面暂无可用的对比维度。
临床背景
This comparison arises for type 2 diabetes patients considering oral SGLT2 inhibitors versus injectable amylin analogs as add-on therapy, especially those on insulin.
结论
Canagliflozin is typically preferred for convenience and extra benefits in type 2 diabetes, while Pramlintide fills a niche for insulin-treated patients; choice is individualized.
全部药物对比